Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Breast Reconstruction Market is Expected to Reach $647 million | MarketsandMarkets.

Published

on

<!– Name:DistributionId Value:8834267 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1206067 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:a9772744-e137-494e-a0ec-b81c35d9067a –>

Chicago, May 10, 2023 (GLOBE NEWSWIRE) — The breast reconstruction industry is expected to witness significant advancements and growth in the near future. With the increasing focus on breast cancer awareness and improved patient outcomes, breast reconstruction procedures are becoming more prevalent. Technological advancements, such as 3D printing, tissue engineering, and surgical robotics, are poised to revolutionize the field of breast reconstruction. These innovations offer personalized and more natural-looking reconstruction options for breast cancer survivors, providing them with improved aesthetics and psychological well-being. Furthermore, the development of novel biomaterials, implant technologies, and surgical techniques will enhance the safety and efficacy of breast reconstruction procedures. The integration of virtual reality, augmented reality, and artificial intelligence may also play a role in surgical planning and simulation, improving precision and patient outcomes. As breast reconstruction continues to evolve, the industry will strive to meet the increasing demand for innovative and patient-centric solutions, ultimately improving the quality of life for breast cancer survivors in the near future.

Breast Reconstruction market in terms of revenue was estimated to be worth $567 million in 2021 and is poised to reach $647 million by 2026, growing at a CAGR of 2.7% from 2021 to 2026 according to a latest report published by MarketsandMarkets™.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186501593

Breast Reconstruction Market Scope:

Report Coverage Details
Market Revenue in 2021 $567 million
Estimated Value by 2026 $647 million
Growth Rate Poised to grow at a CAGR of 2.7%
Market Size Available for 2019–2026
Forecast Period 2021–2026
Forecast Units Value (USD Million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Product, Procedure, Type, End User and Region
Geographies Covered North America, Europe, APAC, MEA, and Latin America
Report Highlights Updated financial information / product portfolio of players
Key Market Opportunity Development of 3D-printed implants
Key Market Drivers Increasing awareness regarding breast reconstruction treatment

Breast implants accounted for the largest share of the breast reconstruction market, by product.

Based on the product, the breast reconstruction market is segmented into breast implants, tissue expanders, and acellular dermal matrix. The breast implants segment accounted for the largest market share.

By procedure, the immediate procedures segment accounted for the largest market share.

Based on the procedure, the breast reconstruction market is segmented into immediate, delayed, and revision procedures. The immediate procedures segment accounted for the largest market share. This is primarily attributed to the increasing number of surgeries post-mastectomy and rising awareness.

By type, the unilateral segment accounted for the largest market share.

Based on type, the breast reconstruction market is segmented into unilateral and bilateral. The unilateral segment accounted for the largest market share. The increasing incidence of breast cancer and rising awareness are major factors responsible for the dominant share of this segment.

North America was the largest regional segment of the breast reconstruction market.

By region, the breast reconstruction market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest market share, followed by Europe. This is attributed to factors such as the rising incidences of breast cancer, increasing awareness of breast reconstruction, and technology advancement and quality improvement leads to FDA approvals for breast reconstruction products

Key Market Players:

The prominent players operating in the global breast reconstruction market are Mentor Worldwide LLC (Johnson & Johnson) (US), Allergan Aesthetics (an Abbvie company) (US), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), POLYTECH Health & Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (US), and Silimed (Brazil).

Enquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=186501593

Hypothetic Challenges of Breast Reconstruction Market in Near Future:

  • Access to healthcare: Limited access to healthcare services, especially for underserved populations or those in remote areas, can pose a challenge for breast reconstruction. Disparities in healthcare infrastructure, availability of specialized surgeons, and financial constraints may hinder the accessibility of breast reconstruction procedures for some individuals.
  • Cost and insurance coverage: Breast reconstruction procedures can be costly, and insurance coverage may vary. The affordability of these procedures and the extent of insurance coverage can be a challenge for individuals seeking breast reconstruction. High out-of-pocket expenses or limited coverage may restrict access to reconstruction options and impact decision-making for patients.
  • Psychological support and patient education: Breast reconstruction is not solely a physical procedure but also has significant psychological and emotional implications for patients. Providing adequate psychological support, counseling, and patient education about the available options, potential outcomes, and post-surgical expectations are crucial. Ensuring that patients are well-informed and have access to appropriate support services can be a challenge in the near future.
  • Post-surgical complications and long-term outcomes: Like any surgical procedure, breast reconstruction carries risks and potential complications. Ensuring optimal post-surgical care, managing complications, and monitoring long-term outcomes are challenges that healthcare providers and patients may face. Continuous monitoring, follow-up care, and addressing potential complications or concerns are vital for successful breast reconstruction outcomes.
  • Technological advancements and innovation: While technological advancements offer promising possibilities for breast reconstruction, their integration into clinical practice can present challenges. Adoption of new technologies, training of healthcare professionals, and ensuring their availability across healthcare facilities can be a hurdle. Balancing the benefits of innovation with safety, effectiveness, and cost considerations is an ongoing challenge in the field.

Top 3 Use Cases of Breast Reconstruction Market:

  • Breast Cancer Reconstruction: The primary use case of breast reconstruction is in the context of breast cancer treatment. After undergoing a mastectomy or lumpectomy to remove breast tissue, breast reconstruction procedures are performed to restore the shape, volume, and symmetry of the breasts. This helps improve the psychological well-being, body image, and self-esteem of breast cancer survivors, facilitating their emotional and physical recovery.
  • Congenital Breast Abnormalities: Breast reconstruction is also used to address congenital breast abnormalities, such as Poland syndrome or tuberous breast deformity. These conditions can cause asymmetry, underdevelopment, or other structural abnormalities in the breasts. Breast reconstruction procedures can help correct these congenital issues and restore a more natural appearance to the breasts, improving the overall quality of life and self-confidence of individuals affected by such conditions.
  • Prophylactic Mastectomy Reconstruction: In cases where individuals are at high risk of developing breast cancer due to genetic mutations (e.g., BRCA1 or BRCA2), they may opt for a prophylactic mastectomy to reduce their risk. Breast reconstruction procedures can be performed immediately following the mastectomy or at a later stage to reconstruct the breasts. Prophylactic mastectomy reconstruction provides individuals with a sense of control over their health and allows them to regain a sense of wholeness and normalcy.

Recent Developments:

  • In 2022, Mentor Worldwide LLC (Johnson & Johnson) received the US FDA approved a new MENTOR Memory Gel boost breast implant
  • In 2021, POLYTECH Health & Aesthetics received US FDA approval for the company’s textured breast implants (macrotextured and polyurethane-coated implants)
  • In 2020, Sientra received US FDA pre-market approval for its OPUS-branded breast implant products

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=186501593

Related Reports:

Soft Tissue Repair Market

Medical Aesthetics Market

Breast Lesion Localization Market

Ambulatory Surgical Centers Market

Plastic Surgery Instruments Market


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Management ‘bought the AI hype’ and expect value but research shows lack of organizational readiness is primary hurdle: IFS

Published

on

management-‘bought-the-ai-hype’-and-expect-value-but-research-shows-lack-of-organizational-readiness-is-primary-hurdle:-ifs

IFS commissioned research shows value creation lags AI promise without the right planning and application
LONDON, April 23, 2024 /PRNewswire/ — New research from IFS, the global cloud enterprise software company, has found that executive and board leadership have ‘bought the AI hype’ but organizations are unable to deliver operationally on expectations. The new global study of 1,700 senior decision makers, Industrial AI: the new frontier for productivity, innovation and competition, found that the promise of AI is being held back by technology, processes and skills. Half of respondents remain optimistic that with the right AI strategy, value can be realized in the next two years, and a quarter believe in the next year.

Expectations failing to meet reality
84% of executives anticipate massive organizational benefits from AI, with the top three areas AI is expected to deliver value in being high-impact: product & service innovation, improved internal & external data availability, and cost reductions & margin gains. The hype has become so high that 82% of senior decision-makers acknowledge that there is significant pressure to adopt AI quickly. However, this same group of respondents state that they are concerned that a failure to plan, implement and communicate properly means AI projects will stall in pilot stage.
Many organizations have not prioritized elements of development, nor have the infrastructure required to reap the rewards or the skills to deliver on that promise. The study found that over a third (34%) of businesses had not moved to the cloud. While this is not essential to AI adoption, it is indicative of an unprepared enterprise unlikely to be able to scale AI across their business. According to IFS, a robust Industrial AI strategy requires a potent combination of cloud, data, processes, and skills. 80% of respondents agree that the lack of a strategic approach means they have insufficient skills in-house to successfully adopt AI. This sentiment is seen elsewhere in the research with 43% of respondents rating the quality of AI resources in their business, in terms of human skills, as passable and not where it needs to be.
Christian Pedersen, Chief Product Officer, IFS, commented: “AI is poised to become the most transformational enterprise tool ever seen, but our research reveals that there are still fundamental misunderstandings about how to harness its power within an industrial setting. It is telling that AI is expected to significantly reduce costs and raise margins, but a lack of robust strategy means most businesses are under-skilled and under-prepared to achieve these ambitions. We built IFS.ai specifically with these challenges in mind. AI value simply will not be found in a single AI capability but instead by delivering AI across all products and business processes. This supports customers’ decision cycles and provides the data and AI services required to realize value faster.”
Pedersen continued: “Achieving this at scale needs a clear-eyed strategic focus, including the high-impact use cases specific to their industry, having a cloud-based infrastructure in place which has industrial AI embedded, and investing early in developing the skills needed. Adopting this approach will turn the tide of disillusionment, and deliver the benefits that boards and the C suite are demanding.”
Outlook optimistic but planning needed
The unfortunate reality of the skills gap means that in terms of AI readiness, many businesses are falling behind. IFS found that nearly half of respondents (48%) were most likely to say that they are gathering proposals and were much less likely to have a clear strategy and perceivable results (27%). A fifth of respondents are in the research phase, with uncontrolled tests taking place and a further 5% are lacking a coordinated approach and do not have anything in motion yet. Despite initial challenges, there is still optimism with respondents most likely to feel AI could make a significant difference to their business in 1-2 years (47%), and a further quarter (24%) believe it could be within a year.
In particular, respondents are most optimistic about the impact of AI in smart production and/or service delivery on effectiveness & business and operational management (22%) in the future. One fifth see the biggest impact being on innovation with new products and services (20%), growth & business model decision-making (20%), empowering people and increasing talent retention (19%), and customer experience and customer service (19%).
Action needed on data readiness
To reap these benefits, enterprises need to leverage the most strategic asset they have – their data. The right data volume and quality is critical for the success of AI applications. Respondents recognize how important real-time data is to successful AI projects, with over 4 in 5 (86%) stating this. Yet despite this recognition, less than a quarter (23%) of respondents have completed their data foundation with it supporting both data-driven business decision making and real time response to changes, suggesting that more work needs to be done to get data AI ready. Moreover, under half (43%) of respondents have majority structured data, with some unstructured.
Pedersen commented: “The lack of maturity at the data foundation layer needs to be addressed as part of an overall AI strategy, otherwise AI simply will never be the magic bullet that can turbocharge the enterprise. Clearly enterprises need support on data management and migration. While AI is seen as a shiny new tool that will revolutionize business, like all technology, it is never that simple. The power of Industrial AI is that it can touch all facets of a business from product innovation and customer experience to productivity and ESG. Its potential is massive if executives and organizations can combine vision, strategy, technology and skills. Now is the time to step back, take stock, and build a true Industrial AI plan and turn the hype into reality.”
Methodology:
Censuswide surveyed 1,709 C-level/President/SVP/Directors who work in Manufacturing, Telecommunications, A&D, Services, Construction & Engineering or Energy & resources in organizations with $50m+ annual revenue (Aged 18+) across the UK, USA, Canada, Germany, France, UAE, Norway, Japan, Australia, Sweden, Denmark and Finland between 06.03.2024 – 27.03.2024.
IFS Press Contacts:MEA& APJ: Adam GillbeCorporate CommunicationsEmail: [email protected] Phone: +44 7775 114 856
USA: Mairi MorganCorporate CommunicationsEmail: [email protected] Phone: +44 7918 607 299
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/ifs/r/management–bought-the-ai-hype–and-expect-value-but-research-shows-lack-of-organizational-readiness,c3965172
The following files are available for download:
https://mb.cision.com/Main/855/3965172/2749130.pdf
Release
https://news.cision.com/ifs/i/ai-research-1-930×423,c3292255
AI-Research-1-930×423
 

View original content:https://www.prnewswire.co.uk/news-releases/management-bought-the-ai-hype-and-expect-value-but-research-shows-lack-of-organizational-readiness-is-primary-hurdle-ifs-302124351.html

Continue Reading

Artificial Intelligence

University medical centers in Germany choose Sectra’s radiology solution to streamline workflows and shorten lead times for patients

Published

on

university-medical-centers-in-germany-choose-sectra’s-radiology-solution-to-streamline-workflows-and-shorten-lead-times-for-patients

LINKÖPING, Sweden, April 23, 2024 /PRNewswire/ — International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed two contracts to provide the radiology module of its enterprise imaging solution with two university medical centers in Germany—Universitätsklinikum Tübingen and Universitätsmedizin Göttingen. By implementing Sectra’s radiology solution, the hospitals aim to improve and streamline radiology workflows with Sectra’s tools for enhanced reporting efficiency, in turn speeding up diagnostics.

“When choosing a vendor, we wanted one that could provide us with a stable and fast system. We also wanted one facilitating collaboration among our radiologists. That way we can streamline our radiology workflows and in turn shorten lead times for patients as well as reduce the ever increasing workload for radiologists,” says Dr. Babak Panahi, Managing Senior Physician and Head of CT and CT Intervention, Universitätsmedizin Göttingen.
Universitätsmedizin Göttingen and Universitätsklinikum Tübingen are two university medical centers located in the cities of Göttingen and Tübingen in Germany managing 300,000 and 600,000 radiology exams a year. The two separate contracts for Sectra’s radiology solution were both signed during the third quarter of Sectra’s 2023/2024 fiscal year.
“Radiologists are under a lot of pressure as they are challenged to handle more images and more complex cases with less resources. Having a solution designed to streamline radiology workflows, facilitating reading and reporting of images, is therefore paramount. I am happy and excited to support Universitätsmedizin Göttingen and Universitätsklinikum Tübingen on their journey towards efficient radiology diagnostics,” says Guido Bötticher, Managing Director, Sectra DACH.
The radiology module is part of Sectra’s enterprise imaging solution that provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Visit Sectra’s website to read more about Sectra and why it’s top-ranked in ‘Best in KLAS’.
About SectraSectra contributes to a healthier and safer society by assisting health systems throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. The company, founded in 1978, is headquartered in Linköping, Sweden, with direct sales in 19 countries, and distribution partners worldwide. Sales in the 2022/2023 fiscal year totaled SEK 2,351 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit Sectra’s website.
For further information, please contact: Dr. Torbjörn Kronander, CEO and President Sectra  AB, 46 (0) 705 23 52 27Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, 46 (0)708 23 56 10
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/sectra/r/university-medical-centers-in-germany-choose-sectra-s-radiology-solution-to-streamline-workflows-and,c3965089
The following files are available for download:
https://news.cision.com/sectra/i/sectra-s-radiology-solution,c3291783
Sectra’s radiology solution
 

View original content:https://www.prnewswire.co.uk/news-releases/university-medical-centers-in-germany-choose-sectras-radiology-solution-to-streamline-workflows-and-shorten-lead-times-for-patients-302124211.html

Continue Reading

Artificial Intelligence

New CPS Protection Platform: TXOne Networks Unveils SageOne at GISec Global

Published

on

new-cps-protection-platform:-txone-networks-unveils-sageone-at-gisec-global

TAIPEI, April 23, 2024 /PRNewswire/ — TXOne Networks, a frontrunner in the realm of cyber-physical systems (CPS) security, is set to unveil its groundbreaking CPS security platform, SageOne, at the highly anticipated GISec Global from April 23rd to 25th, 2024. Attendees can find TXOne Networks showcasing SageOne at stand B99 in hall 5. This innovative platform consolidates all CPS security products onto a single, central management platform, promising streamlined operations and optimized threat detection capabilities.

SageOne, aptly named “Wise Man Number One,” serves as a comprehensive management console providing a holistic view of the CPS attack surface within operational technology (OT) environments. By enabling centralized control of TXOne’s three core product lines – Stellar for endpoint protection, Element for security inspection, and Edge for network defense – SageOne facilitates integrated OT security throughout the lifecycle of protected assets, ensuring robust threat detection and response mechanisms.
Key features of SageOne include:
CPS Attack Surface Management: Prioritizing operational security by offering clear visibility into the overall security posture of OT environments, SageOne identifies security focal points, illuminating asset information and security controls.Integrated Lifecycle Protection: Through centralized management, SageOne simplifies cybersecurity governance and fosters collaborative defense. It serves as an abstraction layer, facilitating contextualization and consolidation of data across multiple products, offering tailored, task-oriented consoles for executives, security personnel, and plant leaders.CPS Threat Detection & Response: SageOne aggregates security insights from various solutions to scout for potential risks, enabling early caution and response to both known and unknown threats.SageOne’s foundation rests upon advanced components, including Threat Intelligence, Behavior-Based AI Analytics Engines, Compliance Framework, Data Visualizer, and Ecosystem Integrator, ensuring comprehensive protection and seamless integration of different tools and technologies.
With its focus on analyzing unexpected behavior and unknown threats, SageOne enables the identification of suspicious events through cross-telemetry analysis within the OT-native XDR engine. This amalgamation of advanced technologies and user-friendly interface ensures the protection of critical infrastructures.
For rapid threat response, SageOne issues early warnings of suspicious behavior and orchestrates cross-telemetry analysis for CPS Threat Detection & Response. Integrated Lifecycle Protection ensures the security of devices and systems throughout their service life, contributing to great cost efficiency.
TXOne Networks reaffirms its commitment to CPS security and continuous advancement in OT security through SageOne. Visit TXOne Networks at the GISec Global from April 23rd to 25th, 2024, at stand B99 in hall 5.
For further updates and information, follow TXOne Networks on the blog, Twitter, and LinkedIn.
About TXOne Networks:
TXOne Networks provides OT security products ensuring reliability and security in industrial control systems and operational technology environments through the OT Zero Trust methodology. Collaborating with leading industrial manufacturers and critical infrastructure operators, TXOne Networks offers practical and business-friendly approaches to OT defense. Its network and endpoint-based products secure OT networks and mission-critical devices in real-time with high security depth.
Website: www.txone.com 
Photo – https://mma.prnewswire.com/media/2389611/SageOne_header_3.jpg

View original content:https://www.prnewswire.co.uk/news-releases/new-cps-protection-platform-txone-networks-unveils-sageone-at-gisec-global-302119386.html

Continue Reading

Trending